Last updated: October 26, 2021
Sponsor: Foundation for Innovative New Diagnostics, Switzerland
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pneumonia
Stomach Discomfort
Lactose Intolerance
Treatment
N/AClinical Study ID
NCT05050825
FE007
Ages 6-15 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ongoing fever or diarrhea
- ongoing fever will be defined objectively or as a reported fever, defined as :axillary temperature ≥37.5°C or tympanic, oral or rectal temperature ≥38.0°C; andfever duration ≤ 10 days
- ongoing diarrhea will be defined as at least 3 abnormal stools during the last 24hrs
- First consultation for the current illness
- Feasibility of contact between the patient (or his/her designated relative) and thestudy team at day 3 and day 7
- Written informed consent by the caretaker/legally acceptable representative
Exclusion
Exclusion Criteria:
- Infants less than 6 months of age
- Age ≥ 15 years
- Clinical status requiring immediate transfer to an appropriate care facility/ severeillness
Study Design
Total Participants: 470
Study Start date:
May 03, 2021
Estimated Completion Date:
December 15, 2021
Connect with a study center
PS Ndiaye-Fatick
Fatick,
SenegalActive - Recruiting
PS Kedougou-Dalaba
Kedougou,
SenegalActive - Recruiting
PS Mbour-Toucouleur
Mbour,
SenegalActive - Recruiting
PS Pont-Tambacounda
Tambacounda,
SenegalActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.